Stacey Ma
Förmögenhet: 708 989 $ per 2026-05-31
Förmögenhet: 708 989 $ per 2026-05-31
Dr. Stacey Y.
Ma is an Independent Director at Elanco Animal Health, Inc., an EVP-Pharmaceutical Development & Manufacturing at Gilead Sciences, Inc. and an Independent Director at Atreca, Inc. She is on the Board of Directors at Elanco Animal Health, Inc. and Atreca, Inc. Dr. Ma was previously employed as an Executive VP & Head-Technical Operations by Sana Biotechnology, Inc. and a Global Head-Pharma Technical Innovation by Genentech, Inc. She received her undergraduate degree from the University of Minnesota, a graduate degree from Yale University and a doctorate degree from Yale University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-21 | 29 727 ( 0,01 % ) | 708 989 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| ATRECA, INC. | Direktör/Styrelseledamot | 2021-07-14 |
| GILEAD SCIENCES, INC. | Företagsledare/Principal | 2022-07-18 |
| ELANCO ANIMAL HEALTH INCORPORATED | Direktör/Styrelseledamot | 2024-11-12 |
| Företag | Position | Slut |
|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | 2019-03-01 |
| SANA BIOTECHNOLOGY, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Atreca, Inc.
Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elanco Animal Health, Inc.
Elanco Animal Health, Inc. BiotechnologyHealth Technology Develops parasitic-ides, vaccines, therapeutics, medicated feed additives and injectable antibiotics | Health Technology |
Sana Biotechnology, Inc.
Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån